ASPIRA PATHLAB & DIAGNOSTICS | INDRAPRASTHA MEDICAL | ASPIRA PATHLAB & DIAGNOSTICS / INDRAPRASTHA MEDICAL |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.4 | 21.3 | - | View Chart |
P/BV | x | 2.6 | 6.3 | 40.3% | View Chart |
Dividend Yield | % | 0.0 | 1.1 | - |
ASPIRA PATHLAB & DIAGNOSTICS INDRAPRASTHA MEDICAL |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
INDRAPRASTHA MEDICAL Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / INDRAPRASTHA MEDICAL |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 94 | 79.7% | |
Low | Rs | 26 | 52 | 49.3% | |
Sales per share (Unadj.) | Rs | 14.0 | 119.9 | 11.7% | |
Earnings per share (Unadj.) | Rs | -0.1 | 9.4 | -0.9% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 13.7 | 10.6% | |
Dividends per share (Unadj.) | Rs | 0 | 3.00 | 0.0% | |
Avg Dividend yield | % | 0 | 4.1 | 0.0% | |
Book value per share (Unadj.) | Rs | 12.4 | 41.4 | 29.9% | |
Shares outstanding (eoy) | m | 10.29 | 91.67 | 11.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 0.6 | 588.0% | |
Avg P/E ratio | x | -583.7 | 7.8 | -7,511.0% | |
P/CF ratio (eoy) | x | 34.6 | 5.3 | 648.3% | |
Price / Book Value ratio | x | 4.1 | 1.8 | 230.3% | |
Dividend payout | % | 0 | 31.9 | -0.0% | |
Avg Mkt Cap | Rs m | 518 | 6,694 | 7.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 2,467 | 2.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 10,987 | 1.3% | |
Other income | Rs m | 3 | 100 | 3.2% | |
Total revenues | Rs m | 148 | 11,087 | 1.3% | |
Gross profit | Rs m | 16 | 1,507 | 1.1% | |
Depreciation | Rs m | 16 | 393 | 4.0% | |
Interest | Rs m | 4 | 43 | 9.7% | |
Profit before tax | Rs m | -1 | 1,172 | -0.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 310 | 0.0% | |
Profit after tax | Rs m | -1 | 862 | -0.1% | |
Gross profit margin | % | 11.0 | 13.7 | 80.3% | |
Effective tax rate | % | 0 | 26.5 | -0.0% | |
Net profit margin | % | -0.6 | 7.8 | -7.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 2,231 | 2.6% | |
Current liabilities | Rs m | 16 | 1,296 | 1.2% | |
Net working cap to sales | % | 29.5 | 8.5 | 347.4% | |
Current ratio | x | 3.7 | 1.7 | 214.7% | |
Inventory Days | Days | 88 | 18 | 485.0% | |
Debtors Days | Days | 590 | 2 | 26,041.7% | |
Net fixed assets | Rs m | 115 | 3,321 | 3.5% | |
Share capital | Rs m | 103 | 917 | 11.2% | |
"Free" reserves | Rs m | 25 | 2,878 | 0.9% | |
Net worth | Rs m | 128 | 3,795 | 3.4% | |
Long term debt | Rs m | 10 | 0 | - | |
Total assets | Rs m | 173 | 5,551 | 3.1% | |
Interest coverage | x | 0.8 | 28.4 | 2.8% | |
Debt to equity ratio | x | 0.1 | 0 | - | |
Sales to assets ratio | x | 0.8 | 2.0 | 42.1% | |
Return on assets | % | 1.9 | 16.3 | 11.6% | |
Return on equity | % | -0.7 | 22.7 | -3.1% | |
Return on capital | % | 2.4 | 32.0 | 7.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 1,905 | 0.0% | |
Fx outflow | Rs m | 0 | 360 | 0.0% | |
Net fx | Rs m | 0 | 1,545 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 1,445 | -0.0% | |
From Investments | Rs m | 2 | -1,079 | -0.1% | |
From Financial Activity | Rs m | -9 | -260 | 3.6% | |
Net Cashflow | Rs m | -8 | 105 | -7.5% |
Indian Promoters | % | 18.7 | 49.4 | 37.9% | |
Foreign collaborators | % | 0.0 | 1.6 | - | |
Indian inst/Mut Fund | % | 0.0 | 6.0 | - | |
FIIs | % | 0.0 | 1.1 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 49.0 | 165.9% | |
Shareholders | 1,512 | 54,158 | 2.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | INDRAPRASTHA MEDICAL | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.14% | -1.11% | 0.45% |
1-Month | -8.93% | 53.80% | 2.55% |
1-Year | -3.33% | 212.41% | 56.14% |
3-Year CAGR | 1.86% | 63.19% | 15.22% |
5-Year CAGR | -1.91% | 46.74% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the INDRAPRASTHA MEDICAL share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of INDRAPRASTHA MEDICAL the stake stands at 51.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of INDRAPRASTHA MEDICAL.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
INDRAPRASTHA MEDICAL paid Rs 3.0, and its dividend payout ratio stood at 31.9%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of INDRAPRASTHA MEDICAL.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.